semaglutide .25 mg Medscape | The FDA has approved once-daily oral 25 (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. ⁠ Obesity | Novo Nordisk U.S.

However, in April 2026, the PIL for Tirzepatide as Mounjaro was updated to state Tirzepatide passes into breastmilk in very low amounts and is not expected to be absorbed by a breastfed newborn/infant

McEvoy JW, McCarthy CP, Bruno RM, et al

Research has identified specific risk factors that increase your likelihood of developing telogen effluvium: Speed of Weight Loss Studies consistently show that losing more than 1-2 pounds per week, especially sustained over several weeks, significantly increases risk

Who is required to fill out the Vitamin Injection Consent Form

Arq Gastroenterol

I feel great taking it, and actually started sleeping better